Risk of Hypertension With Sorafenib Use in Patients With Cancer: A Meta-Analysis From 20,494 Patients

American Journal of Therapeutics
Xiongwen YangYingzhang Cheng

Abstract

Sorafenib is a new multikinase inhibitor; the incidence of hypertension (HTN) with sorafenib has been reported to vary substantially among clinical trials. We searched multiple databases to investigate the risk of sorafenib-induced HTN in patients with cancer. A total of 93 trials involving 20,494 patients were selected for this meta-analysis. The relative risks (RRs) of all-grade and high-grade HTN associated with sorafenib were 3.06 (P < 0.001) and 3.33 (P < 0.001). There are no significantly RRs of all-grade, 0.81 (P = 0.047), and high-grade HTN, 0.64 (P = 0.075), in sorafenib monotherapy versus other multitargeted antiangiogenic tyrosine kinase inhibitors. The incidence of sorafenib-associated all-grade and high-grade HTN was 21.3% (P < 0.001) and 5.9% (P < 0.001), respectively. The patients with renal cell carcinoma (RCC) and thyroid cancer have high incidence (≥20%) of sorafenib-associated all-grade HTN and high incidence (≥5%) of sorafenib-associated high-grade HTN. The trials with median treatment duration ≥ 4, 5, and 7 months were 21.0% (P < 0.001), 25.4% (P < 0.001), and 27.6% (P < 0.001); progression-free survival ≥ 6, 9, and 12 months were 24.5% (P < 0.001), 26.8% (P < 0.001), and 32.8% (P < 0.001); and overall surv...Continue Reading

References

Aug 1, 1995·Nature Medicine·O IliopoulosW G Kaelin
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·A de La CosteC Perret
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tanya Ahmad, Tim Eisen
Nov 23, 2005·Oncology·Peter Carmeliet
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Domenic A Sica
Mar 2, 2006·Journal of the National Cancer Institute·Francesca CarlomagnoMassimo Santoro
Apr 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark J RatainPeter J O'Dwyer
Aug 2, 2006·British Journal of Cancer·T EisenM J Ratain
Oct 4, 2006·Nature Reviews. Drug Discovery·Scott WilhelmSusan Kelley
Aug 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine ElserEric X Chen
Nov 28, 2007·Clinical Colorectal Cancer·Cristina GrávalosEsther Holgado
Dec 7, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K N ChiL Seymour
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William L DahutWilliam D Figg
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David F McDermottEvan Hersh
Jun 11, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vandana Gupta-AbramsonMarcia S Brose
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Dec 3, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alvaro Moreno-AspitiaEdith A Perez
Jan 20, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H IzzedineJ P Spano
Jan 22, 2009·BJU International·Jeanny B Aragon-ChingWilliam L Dahut
Jan 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard T KloosManisha H Shah
Apr 15, 2009·Anti-cancer Drugs·Paulo Cortes
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert G MakiGary K Schwartz
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe Di LorenzoSabino De Placido
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George R BlumenscheinMartin Reck
Feb 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Lance CoweyW Kimryn Rathmell
Mar 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio ScagliottiNasser Hanna
Mar 31, 2010·Journal of the National Cancer Institute·Michael L MaitlandUNKNOWN Cardiovascular Toxicities Panel, Convened by the Angiogenesis Task Force of the National Cancer Institute Investigational Dr
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elaine T LamManisha H Shah
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen K WilliamsonSusan G Urba
Jul 10, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Joaquim BellmuntLeyrer Urruticoechea
Aug 26, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sarita DubeyHedy Lee Kindler

❮ Previous
Next ❯

Citations

Jan 10, 2019·Journal of Hypertension·Vasiliki KatsiDimitrios Tousoulis
Jul 10, 2021·Clinical Science·Aristeidis SionakidisSandosh Padmanabhan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.